Literature DB >> 2153179

Retinoic acid inhibits the production of collagenase by human epidermal keratinocytes.

C Bailly1, S Drèze, D Asselineau, B Nusgens, C M Lapière, M Darmon.   

Abstract

Lattices made of collagen and fibroblasts can be used as dermal equivalents to grow human keratinocytes in vitro. When these cultures are performed in a medium containing delipidized serum, the lattice is eventually degraded by the growing epithelium. The digestion of the dermal equivalent is due to the secretion of a collagenase by the keratinocytes. This degradation does not occur in cultures containing total serum or supplemented with retinoic acid. We show in this paper that retinoic acid inhibits the secretion of this keratinocyte collagenase in a dose-dependent manner. In the light of this result, the possible involvement of collagenase inhibition in the therapeutic effect of retinoic acid in skin disorders and skin aging must be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153179     DOI: 10.1111/1523-1747.ep12873342

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Multistep production of bioengineered skin substitutes: sequential modulation of culture conditions.

Authors:  F A Auger; R Pouliot; N Tremblay; R Guignard; P Noël; J Juhasz; L Germain; F Goulet
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

2.  Skin equivalent produced with human collagen.

Authors:  F A Auger; C A López Valle; R Guignard; N Tremblay; B Noël; F Goulet; L Germain
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-06       Impact factor: 2.416

3.  Keratinocytes modulate the biosynthetic phenotype of dermal fibroblasts at a pretranslational level in a human skin equivalent.

Authors:  M Lacroix; T Bovy; B V Nusgens; C M Lapière
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 4.  Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications.

Authors:  F A Auger; M Rouabhia; F Goulet; F Berthod; V Moulin; L Germain
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

5.  Effect of cell-cell and cell-matrix interactions on the response of fibroblasts to epidermal growth factor in vitro. Expression of collagen type I, collagenase, stromelysin and tissue inhibitor of metalloproteinases.

Authors:  A C Colige; C A Lambert; B V Nusgens; C M Lapière
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

6.  Effect of Porphyromonas gingivalis on epithelial cell MMP-9 type IV collagenase production.

Authors:  P Fravalo; C Ménard; M Bonnaure-Mallet
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion.

Authors:  J Varani; B Burmeister; R G Sitrin; S B Shollenberger; D R Inman; S E Fligiel; D F Gibbs; K Johnson
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  Epidermis reconstructed from the outer root sheath of human hair follicle. Effect of retinoic acid.

Authors:  M C Lenoir-Viale; C Galup; M Darmon; B A Bernard
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Human skin in organ culture. Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors.

Authors:  J Varani; P Perone; D R Inman; W Burmeister; S B Schollenberger; S E Fligiel; R G Sitrin; K J Johnson
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Influence of aging, localization, glucocorticoids and isotretinoin on matrix metalloproteases 2 (MMP-2) and 9 (MMP-9) in suction blister fluids.

Authors:  M Kylmäniemio; P Autio; A Oikarinen
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.